PsychBright Health is a psychiatrist-led practice in Los Angeles where board-certified psychiatrists and psychiatric mental health nurse practitioners treat methamphetamine and stimulant use disorder, including cocaine and prescription stimulant addiction, with psychiatrist supervision and clinical oversight throughout. New patients are typically seen within five business days. We accept Medicare Advantage, Medicare, Aetna, Anthem, Blue Cross, Blue Shield, Cigna and Evernorth, UHC, Optum, Health Net, L.A. Care Commercial, SCAN, Carelon, Tricare, and Triwest, along with most major commercial health plans, and if your plan is not listed there is a strong chance we still accept it. Care is delivered entirely by telehealth, to any resident of California.
Stimulant use disorder is a diagnosable medical condition in which a person keeps using a stimulant, such as methamphetamine, cocaine, or a prescription stimulant, despite clear harm to their health, relationships, work, or finances. It is not a lack of willpower. Repeated stimulant use physically changes the brain’s reward and stress systems, which is why cravings feel overwhelming and why stopping without help is so hard.
According to the Substance Abuse and Mental Health Services Administration, about 2.7 million people aged 12 or older used methamphetamine in the past year in 2022. In Los Angeles, that reality shows up in emergency rooms, in families, and in workplaces every day, and it often arrives alongside anxiety, depression, or paranoia that make the addiction even harder to face alone.
The line between using a stimulant and having a stimulant use disorder is crossed when use becomes compulsive and consequences stop being a deterrent. Psychiatrists diagnose it using the criteria in the DSM-5, and the more of the following that are present, the more severe the disorder.
Left untreated, stimulant use disorder can lead to heart attack, stroke, severe dental decay, skin sores, dramatic weight loss, psychosis, and a rising risk of overdose. The physical toll is real, and so is the mental health toll, which is part of why early treatment matters.
There is no medication approved by the U.S. Food and Drug Administration specifically to treat methamphetamine or stimulant use disorder, so honest treatment does not lead with a pill. The strongest evidence supports behavioral treatment, and a board-certified psychiatrist builds a plan around it while managing the medical and psychiatric side of recovery.
Treatment at PsychBright generally combines the following, tailored to the individual after a full evaluation:
Recovery is rarely linear, and results may vary from one person to the next. What a psychiatrist provides is a plan that adjusts as you go, rather than a single intervention that either works or does not. When opioids are also part of the picture, our medication-assisted treatment options can be coordinated within the same practice.
Getting to a psychiatrist should not be the hardest part of getting better. PsychBright is a Los Angeles practice serving West Hollywood, Beverly Hills, Santa Monica, Culver City, and Brentwood, though anyone who has parked near S Beverly Dr at rush hour knows the drive is not always simple. That is exactly why telehealth matters here. PsychBright offers telehealth psychiatry to any California resident, so a person in the San Fernando Valley, Long Beach, or three hours up the coast can start treatment without a commute.
Waiting is also harder to justify here than it used to be. According to Los Angeles County Public Health, stimulant and opioid co-involved deaths accounted for 38 percent of all accidental overdose deaths in the county in 2024, and the county recommends fentanyl test strips because contamination cannot be seen, smelled, or tasted. Countywide overdose deaths did fall 22 percent that year, so the direction is good, but a stimulant user in Los Angeles now carries an opioid risk they never chose. That is a reason to work with a physician who follows the local data rather than to wait it out.
The other half of the problem is supply. Large parts of Los Angeles County are federally designated Mental Health Professional Shortage Areas, and California is projected to fall thousands of psychiatrists short of demand. That shortage is why the wait to be seen is often the real barrier, and it is the reason same-week scheduling matters more here than it would in a city with slack in the system.
On the cost side, PsychBright is in-network with Medicare Advantage, Medicare, Aetna, Anthem, Blue Cross, Blue Shield, Cigna and Evernorth, UHC, Optum, Health Net, L.A. Care Commercial, SCAN, Carelon, Tricare, and Triwest. Medicare Advantage acceptance is where PsychBright stands apart from most psychiatric practices in Los Angeles, which matters for older adults whose stimulant use often hides behind a fatigue or memory complaint. The full list of accepted plans is worth checking first, and the fastest way to confirm your specific plan before booking is to call our team.
What you share with a psychiatrist about stimulant use is protected under HIPAA, and your employer and family cannot access your psychiatric records without your written consent. Substance use records carry additional federal protections on top of that. The narrow exceptions involve imminent risk of serious harm, which the law requires be reported. For many people the fear of being found out is the single biggest barrier to booking, so it is worth stating plainly: seeking treatment is private, and it does not create a public record.
See a psychiatrist when stimulant use is affecting your health, your relationships, or your ability to function, or when you have tried to stop on your own and could not. You do not have to wait until you have lost everything, and you do not have to be certain it is a disorder before you get evaluated.
The first appointment is a psychiatric evaluation. A board-certified psychiatrist reviews your history, your substance use, your mental health, and your goals, and that conversation produces a diagnosis and a plan built for you. Whether medication is part of that plan depends on what the evaluation shows. Bilingual care is available in Spanish for patients who prefer it.
Consider the account manager who started using methamphetamine to keep up with two jobs, then found the drug running the schedule instead. He had not slept properly in weeks, his partner had stopped asking where he was, and he was terrified that asking for help would end his career. What he needed was not a lecture. He needed a board-certified psychiatrist who could treat the addiction and the exhaustion and the paranoia as one problem, privately, and quickly.
That is the care PsychBright is built to deliver:
If you are weighing whether to reach out, call (213) 584-2331 and the team can verify your coverage and get you scheduled the same week. Stimulant use rarely arrives on its own, and broader substance use care is available alongside it.
| Stage | When | What happens |
|---|---|---|
| Request an appointment | Day 0 | Call or submit the form. The team verifies your insurance benefits before booking, so cost is settled up front. |
| Psychiatric evaluation | Typically within 5 business days | A board-certified psychiatrist reviews your stimulant use, sleep, mood, physical health, and any prior treatment, by video. |
| Plan built around behavioral treatment | Same visit | Contingency management and CBT lead, because that is where the evidence is. Medication is added only where it has a job to do. |
| Early stabilization | First weeks | Closer follow-up through the crash and sleep disruption, when relapse risk is highest. Co-occurring depression, anxiety, or psychosis is treated alongside. |
| Ongoing care | Month 2 onward | Visits space out as things stabilize. Recovery timelines differ from person to person and results may vary. |
Daniel Duel, MD, is a board-certified psychiatrist and the founder and CEO of PsychBright Health, a Beverly Hills based virtual psychiatry practice serving adults throughout California. Dr. Duel completed his medical and psychiatric training at UCLA, where he gained extensive experience treating a wide range of conditions, including depression, anxiety, bipolar disorder, psychotic disorders, and substance use disorders.
Throughout his career, Dr. Duel has been drawn to the importance of understanding the whole person, not simply treating a list of symptoms. His approach combines thoughtful diagnostic evaluation, evidence-based medication management, supportive therapy, and practical lifestyle interventions tailored to each patient’s needs.
Dr. Duel founded PsychBright Health to make high-quality psychiatric care easier to access while preserving the clinical rigor and personal attention patients deserve. Under his leadership, PsychBright has grown into a multidisciplinary practice in which psychiatric care is delivered by experienced clinicians, including board-certified psychiatrists, with an emphasis on compassion, collaboration, and meaningful long-term improvement.
Yes. Under federal and California mental health parity laws, plans that cover medical care must cover substance use treatment at a comparable level. PsychBright is in-network with Medicare Advantage, Medicare, Aetna, Anthem, Blue Cross, Blue Shield, Cigna and Evernorth, UHC, Optum, Health Net, L.A. Care Commercial, SCAN, Carelon, Tricare, and Triwest, so most patients pay only their plan’s copay. If your plan is not listed, or you want to confirm your specific coverage before booking, call (213) 584-2331 and our team will verify your benefits.
There is no medication approved by the FDA specifically to treat methamphetamine or stimulant use disorder, so any provider promising a cure in a pill is not being honest with you. The most effective treatment is behavioral, especially contingency management and cognitive behavioral therapy. Medication still has a real role, because a psychiatrist can prescribe it to manage withdrawal symptoms, stabilize sleep, and treat co-occurring depression, anxiety, or psychosis. Results may vary from one person to the next.
Yes. PsychBright offers telehealth psychiatry to any California resident, so you can begin and continue treatment from San Diego, the Central Valley, the Bay Area, or anywhere in the state without traveling anywhere. Telehealth visits follow the same clinical standards as in-person care. A narrow set of steps can still require an in-person examination, and your clinician will tell you directly if that applies to you.
The first visit is a psychiatric evaluation. A board-certified psychiatrist reviews your history, your stimulant use, your mental health, and your goals, then works with you on a diagnosis and a treatment plan. It is a conversation, not a judgment. Whether medication is part of the plan depends on what the evaluation shows, and you leave with clear next steps.
No, not without your written consent. Psychiatric records are protected under HIPAA, and substance use treatment records carry additional federal privacy protections. Your employer and family cannot access them on their own. The only exceptions involve an imminent risk of serious harm, which the law requires be reported. For most people, seeking treatment is completely private.
Without insurance, an initial psychiatric evaluation in Los Angeles typically ranges from about $300 to $700, with follow-up appointments costing less. With insurance, most patients pay only their plan’s copay because substance use treatment is a covered benefit under most plans. PsychBright verifies your specific benefits before your first appointment, and self-pay and superbill options are available for out-of-network reimbursement. Call (213) 584-2331 to confirm your cost.
New patients are typically seen within five business days, and telehealth expands that availability because there is no commute across the Westside to schedule around. With stimulant use disorder, the gap between deciding to get help and actually being seen is where relapse often happens, so we keep that gap short on purpose. Call (213) 584-2331 or request an appointment online to find the soonest opening.
Fentanyl contamination of the street stimulant supply is a documented risk in Los Angeles County. County public health data shows that stimulant and opioid co-involved deaths made up 38 percent of all accidental overdose deaths in 2024, and LA County Public Health recommends testing substances with fentanyl test strips before use. You cannot see, smell, or taste fentanyl in methamphetamine. County overdose deaths did fall 22 percent in 2024, so the picture is improving, but the co-involvement risk is real and it is one of the strongest reasons to get treatment now rather than later, with a physician who follows the local data.
For stimulant use disorder, a psychiatrist is usually the right starting point because the condition often involves withdrawal, disrupted sleep, and co-occurring depression, anxiety, or psychosis that need medical management alongside therapy. A therapist provides the talk-based work, and many patients benefit from both. A psychiatrist can diagnose, prescribe when appropriate, coordinate a higher level of care if needed, and oversee the whole plan.
PsychBright Health treats methamphetamine and stimulant use disorder for patients in Los Angeles, West Hollywood, Beverly Hills, Santa Monica, Culver City, and Brentwood from its office at 1180 S Beverly Dr, Suite 700, and by telehealth anywhere in California. Board-certified addiction psychiatry, same-week availability, and insurance including Medicare Advantage. If you are ready to take the first step, call (213) 584-2331 or request an appointment online.
If you or someone you know is in crisis, contact the 988 Suicide and Crisis Lifeline by calling or texting 988.
This page is for informational purposes and is not a substitute for medical advice. Speak with a board-certified psychiatrist about your specific situation.
